Wang Xinxin, Chen Diangang, Gao Jianbao, Long Haixia, Zha Haoran, Zhang Anmei, Shu Chi, Zhou Li, Yang Fei, Zhu Bo, Wu Wei
Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China,
Department of Oncology, The General Hospital of the People's Liberation Army Rocket Force, Beijing, China.
Cancer Manag Res. 2018 Dec 14;10:6971-6984. doi: 10.2147/CMAR.S182852. eCollection 2018.
Centromere protein U (CENPU) abnormally exhibits high expression in various types of human tumor tissues and participates in tumor progression; however, its expression pattern and biological function in lung cancer have not yet been elucidated. In the present study, we explored the clinical significance and biological function of CENPU in lung cancer.
The Cancer Genome Atlas (TCGA) data analyses, quantitative real-time PCR (RT-PCR), and Western blotting were performed to quantify CENPU and FOXM1 expression in non-small-cell lung cancer (NSCLC) samples. Survival data were obtained from Kaplan-Meier plotter or PROGgene V2 prognostic database. The function of CENPU in lung cancer cell proliferation was determined using 5-ethynyl-2'-deoxyuridine (EdU), Cell Counting Kit-8 (CCK-8), and cell cycle assays, and the underlying mechanism was determined through bioinformatic analyses and validated by in vitro siRNA or plasmid transfection experiments.
CENPU was abnormally overexpressed in NSCLC samples compared with matched paired normal tissues. Higher expression of CENPU predicted worse overall survival (OS) and relapse-free survival (RFS) in NSCLC patients. Knockdown of CENPU expression by siRNA significantly inhibited proliferation and delayed cell cycle progression of lung cancer cells. To figure out the mechanism, bioinformatic analyses were performed and the results showed that the transcription factor, FOXM1, positively correlated with CENPU. Further in vitro experiments indicated that FOXM1 was the possible downstream transcription factor of CENPU as the knockdown of CENPU led to lower expression of FOXM1 and the overexpression of FOXM1 significantly reversed the inhibition of proliferation caused by CENPU knockdown. Furthermore, FOXM1 was highly expressed in NSCLC. The knockdown of FOXM1 also attenuated proliferation and induced G1 arrest in lung cancer cells.
CENPU was highly expressed in NSCLC tissues, wherein it promoted lung cancer cell proliferation via the transcription factor, FOXM1, which could be a potential target for therapeutic strategies.
着丝粒蛋白U(CENPU)在多种类型的人类肿瘤组织中异常高表达,并参与肿瘤进展;然而,其在肺癌中的表达模式和生物学功能尚未阐明。在本研究中,我们探讨了CENPU在肺癌中的临床意义和生物学功能。
进行癌症基因组图谱(TCGA)数据分析、定量实时PCR(RT-PCR)和蛋白质印迹法,以定量非小细胞肺癌(NSCLC)样本中CENPU和叉头框蛋白M1(FOXM1)的表达。生存数据来自Kaplan-Meier绘图仪或PROGgene V2预后数据库。使用5-乙炔基-2'-脱氧尿苷(EdU)、细胞计数试剂盒-8(CCK-8)和细胞周期分析来确定CENPU在肺癌细胞增殖中的功能,并通过生物信息学分析确定其潜在机制,并通过体外小干扰RNA(siRNA)或质粒转染实验进行验证。
与配对的正常组织相比,NSCLC样本中CENPU异常过表达。CENPU的高表达预示着NSCLC患者的总生存期(OS)和无复发生存期(RFS)更差。通过siRNA敲低CENPU表达可显著抑制肺癌细胞的增殖并延迟细胞周期进程。为了弄清楚其机制,进行了生物信息学分析,结果表明转录因子FOXM1与CENPU呈正相关。进一步的体外实验表明,FOXM1可能是CENPU的下游转录因子,因为敲低CENPU会导致FOXM1表达降低,而FOXM1的过表达显著逆转了CENPU敲低引起的增殖抑制。此外,FOXM1在NSCLC中高表达。敲低FOXM1也会减弱肺癌细胞的增殖并诱导G1期阻滞。
CENPU在NSCLC组织中高表达,其中它通过转录因子FOXM1促进肺癌细胞增殖,FOXM1可能是治疗策略的潜在靶点。